Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

ToolGen, Inc. Announces Poster Presentation on CRISPR Technology at 2017 American Society of Hematology Annual Meeting


Posted on: 28 Nov 17

SEOUL, South Korea, Nov. 28, 2017 (GLOBE NEWSWIRE) -- ToolGen, Inc. (KONEX, 199800), a biotechnology company specializing in genome editing, today announced a poster presentation on its CRISPR technology at the upcoming American Society of Hematology (ASH) Annual Meeting, being held December 9-12 in Atlanta, Georgia.

The poster presentation entitled CRISPR/Cas9-Mediated Diacylglycerol Kinase Knockout Potentiates Anti-Tumor Efficacy of Human Chimeric Antigen Receptor T-Cells will cover a study that explored a potential solution to tumors evading immune surveillance by deactivating T cells. Researchers strengthened T cell function by deleting Diacylglycerol kinase (DGKs) using CRISPR/Cas9. The study found that the observed biological effects may also yield new strategies for improving the efficacy of T-cell therapy in combination with signal 2 checkpoint inhibitors in clinical applications.

Details of the presentation are below:

Poster 3182 - CRISPR/Cas9-Mediated Diacylglycerol Kinase Knockout
Potentiates Anti-Tumor Efficacy of Human Chimeric Antigen Receptor
T-Cells
Lead Author In-Young Jung, MS
Poster Session: 703: Adoptive Immunotherapy: Poster II
Date: Sunday, December 10, 2017
Time 6:00 - 8:00pm CT
Location Georgia World Congress Center
Building A, Level 1, Hall A2


About ToolGen, Inc.

ToolGen, Inc. is a biotechnology company focused on the development and application of genome editing technologies. It creates and holds intellectual property rights for essential tools and technologies for editing the genetic information in microbial, plant, animal, and human cells. ToolGen’s mission is to translate the potential of its innovative platform technology into transformative products for biomedicine and agriculture. For more information, please visit www.toolgen.com.

Contacts

Company – Seokjoong Kim +82-2-873-8168
Media – Kirsten Thomas (508) 280-6592
Investors – Tram Bui (646) 536-7035

GlobeNewswire
globenewswire.com

Last updated on: 29/11/2017

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.